INTERCEPT PHARMACEUTICALS, INC.·4

Dec 3, 4:34 PM ET

Micheli Francesco 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Dec 3, 2018

Insider Transaction Report

Form 4
Period: 2018-11-29
Transactions
  • Sale

    Common stock, par value $0.001 per share

    2018-11-29$105.07/sh750,000$78,802,5006,095,578 total(indirect: See footnote)
Footnotes (1)
  • [F1]These shares are held by Genextra S.p.A. Mr. Micheli is the Executive Director and Chairman of the board of Genextra S.p.A. and, in such capacity, Mr. Micheli exercises voting control over the shares of common stock owned by Genextra S.p.A and investment control over such shares as authorized by the board of Genextra S.p.A. Mr. Micheli disclaims beneficial ownership with respect to any such shares, except to the extent of his pecuniary interest therein, if any.

Documents

1 file
  • 4
    form4.xmlPrimary